KUHLCKE, H. G. ECKERT, B. FEHSE u. C. BAUM (2002):
Murine leukem Science 296, 497.
MANN, D., M.
LINDE BOCK, M. SCHWEIZER u. A. RETHWILM (1997):
of murine leukemia virus particles with chimeric human foamy virus envelope proteins.
J. Virol. 71
Efficient pseudotyping
, 4815-4820
LINDEMANN, D., u. P. A. GOEPFERT (2003):
The foamy virus envelope glycoproteins.
Curr. Top. Microbiol. Immunol. 277, 111-129
LINIAL
pathogenic?
Trends Microbiol. 8 , M. (2000):
Why aren't foamy viruses , 284-289
LINIAL
l retroviruses.
, M. L. (1999):
Foamy viruses are unconventiona J. Virol. 73, 1747-1755
OCHELT, M. (2003):
L
Foamy virus transactivation and gene expression.
Curr. Top. Microbiol. Immunol. 277, 27-61
LÖCH
er.
ELT, M., W. MURANYI u. R. M. FLÜGEL (1993):
Human foamy virus genome possesses an internal, Bel-1-dependent and functional promot
Proc. Natl. Acad. Sci. U S A 90, 7317-7321
LUSKEY, B. D., M. ROSENBLATT, K. ZSEBO u. D. A. WILLIAMS (1992):
Stem cell factor, interleukin-3, and interleukin-6 promote retroviral-mediated gene transfer into murine hematopoietic stem cells.
Blood 80, 396-402
AZE, R., H. HANENBERG u. D. A. WILLIAMS (1997):
M
Establishing chemoresistance in hematopoietic progenitor cells.
Mol. Med. Today 3, 350-358
MAZE, R., C. KURPAD, A. E. PEGG, L. C. ERICKSON u. D. A. WILLIAMS (1999):
40A, but not P140A/G156A, mutant sferase protects hematopoietic cells against O6-benzylguanine sensitization to chloroethylnitrosourea Retroviral-mediated expression of the P1
form of O6-methylguanine DNA methyltran
treatment.
J. Pharmacol. Exp. Ther. 290, 1467-1474
EIERING, C. D., K. E. COMSTOCK u. M. L. LINIAL (2000):
tions of human foamy virus in persistently infected human M
Multiple integra
erythroleukemia cells.
J. Virol. 74, 1718-1726
MEIERING, C. D., u. M. L. LINIAL (2001):
and infection.
Historical perspective of foamy virus epidemiology Clin. Microbiol. Rev. 14, 165-176
MERGIA, A., S. CHARI, D. L. KOLSON, M. M. GOODENOW u. T. CICCARONE
an foamy virus vector type-1 (SFV-1) in nondividing cells
Virology 280 (2001):
The efficiency of simi and in human PBLs.
, 243-252
MERG
l. Immunol. 277 IA, A., u. M. HEINKELEIN (2003):
Foamy virus vectors.
Curr. Top. Microbio , 131-159
ns.
METCALF, D. (1977):
In-vitro cloning techniques for hemopoietic cells: clinical applicatio Ann. Intern. Med. 87, 483-488
MOCHIZUKI, H., J. P. SCHWARTZ, K. TANAKA, R. O. BRADY u. J. REISER (1998):
High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells.
J. Virol. 72, 8873-8883
MODROW, S, u. D. FALKE u. U. TRUYEN (2002):
Molekulare Virologie.
eidelberg, 750 S.
MOEBES, A., J. ENSSLE, P. D. BIENIASZ, M. HEINKELEIN, D. LINDEMANN, M.
u. A. RETHWILM (1997):
Human foamy virus reverse transcription that occurs late in the viral replication Spektrum der Wissenschaft Verlagsgesellschaft mbH, H
BOCK, M. O. MCCLURE
cycle.
J. Virol. 71, 7305-7311
ORITZ, T., V. P. PATEL u. D. A. WILLIAMS (1994):
oietic cells via retroviral vectors.
M
Bone marrow extracellular matrix molecules improve gene transfer into human hematop
J. Clin. Invest. 93, 1451-1457
MORRISON, S. J., N. UCHIDA u. I. L. WEISSMAN (1995):
The biology of hematopoietic stem cells.
Annu. Rev. Cell. Dev. Biol. 11, 35-71
NALDI . MULLIGAN, F. H. GAGE, I. M.
VERMA u. D. TRONO (1996):
very and stable transduction of nondividing cells by a lentiviral NI, L., U. BLÖMER, P. GALLAY, D. ORY, R
In vivo gene deli vector.
Science 272, 263-267
NAVIAUX, R. K., E. COSTANZI, M. HAAS u. I. M. VERMA (1996):
The pCL system: rapid production of helper-free, high-titer, recombinant retroviruses.
J. Virol. 70, 5701-5705
NEFF, T., B. C. BEARD, L. J. PETERSON, P. ANANDAKUMAR, J. THOMPSON u.
l of drug resistance gene therapy.
H. P. KIEM (2005):
Polyclonal chemoprotection against temozolomide in a large-animal mode
Blood 105, 997-1002
NEFF,
MS, M. SCHMIDT, G. E. GEORGES, C. VON KALLE u. H. P. KIEM
Methylguanine methyltransferase-mediated in vivo selection and rge-animal model.
T., P. A. HORN, L. J. PETERSON, B. M. THOMASSON, J. THOMPSON, D. A.
WILLIA (2003):
chemoprotection of allogeneic stem cells in a la J. Clin. Invest. 112, 1581-1588
NOWR KLANKE, M. HEINKELEIN, M. RAMMLING, T.
DANDEKAR, C. VON KALLE u. A. RETHWILM (2006):
ations into a human cell OUZI, A., M. DITTRICH, C.
Genome-wide mapping of foamy virus vector integr line.
J. Gen. Virol. 87, 1339-1347
OMOTO, S., E. A. BRISIBE, H. OKUYAMA u. Y. R. FUJII (2004):
Feline foamy virus Tas protein is a DNA-binding transactivator.
J. Gen. Virol. 85, 2931-2935
ORKIN, S. H., u. A. G. MOTULSKY (1995):
Report and recommendations of the panel to assess the NIH investment in research on gene therapy.
lrep.html
www.nih.gov/news/pane ; Abrufdatum: 07.12.1995
ce of foamy virus vectors.
PATTON, G. S., O. ERLWEIN u. M. O. MCCLURE (2004):
Cell-cycle dependen
J. Gen. Virol. 85, 2925-2930
PEAR M. L. SCOTT u. D. BALTIMORE (1993):
Production of high-titer helper-free retrovirus by transient infection.
, W. S., G. P. NOLAN,
Proc. Natl. Acad. Sci. USA 90, 8392-8396
PEGG, A. E., M. E. DOLAN u. R. C. MOSCHEL (1995):
Structure, function, and inhibition of O6-alkylguanine-DNA alkyltransferase.
Prog. Nucleic Acid Res. Mol. Biol. 51, 167-223
FEIFER, A., u. I. M. VERMA (2001):
P
Gene therapy: promises and problems.
Annu. Rev. Genomics Hum. Genet. 2, 177-211
PIETSCHMANN, T., M. HEINKELEIN, M. HELDMANN, H. ZENTGRAF, A.
N (1999):
Foamy virus capsids require the cognate envelope protein for particle export.
RETHWILM u. D. LINDEMAN
J. Virol. 73, 2613-2621
POLLO GER, S. GOEBEL, H. HANENBERG u. S. CAI
(2005):
In Vivo Selection of Murine Long-Term Repopulating Cells Transduced with a Foamy Virus Vector That Expresses MGMTP140K.
in: ASH Ann. Meeting, Proc. 106 K, K. E., A. G. ERNSTBER
, 3061
PREUSS, I., S. HAAS, U. EICHHORN, I. EBERHAGEN, M. KAUFMANN, T. BECK,
6):
thyltransferase in human tumor and corresponding normal tissue.
R. H. EIBL, P. DALL, T. BAUKNECHT, J. HENGSTLER, B. M. WITTIG, W.
DIPPOLD u. B. KAINA (199
Activity of the DNA repair protein O6-methylguanine-DNA me
Cancer Detect. Prev. 20, 130-136
QUINN
The DNA-repair gene MGMT and the clinical response of gliomas to alkylating , D. I. (2001):
agents.
N. Engl. J. Med. 344, 686
UINN, J. A., J. PLUDA, M. E. DOLAN, S. DELANEY, R. KAPLAN, J. N. RICH, A. H.
N, O. M. COLVIN, M. M.
M.
-UHLIG, J. E. HERNDON, 2ND, D. D. BIGNER u. H. S. FRIEDMAN (2002):
plus O(6)-benzylguanine for patients with ssive malignant glioma.
Q
FRIEDMAN, D. A. REARDON, J. H. SAMPSO
HAGLUND, A. E. PEGG, R. C. MOSCHEL, R. E. MCLENDON, J.
PROVENZALE, S. GURURANGAN, S. TOURT
Phase II trial of carmustine
nitrosourea-resistant recurrent or progre J. Clin. Oncol. 20, 2277-2283
RADSAK, K., R. FUHRMANN, R. P. FRANKE, D. SCHNEIDER, A. KOLLERT, K. H.
BRUCHER u. D. DRENCKHAHN (1989):
Arch. Virol. 107
Induction by sodium butyrate of cytomegalovirus replication in human endothelial cells.
, 151-158
RAGG, S., M. XU-WELLIVER, J. BAILEY, M. D'SOUZA, R. COOPER, S. CHANDRA, R. SESHADRI, A. E. PEGG u. D. A. WILLIAMS (2000):
Direct reversal of DNA damage by mutant methyltransferase protein protects mice against dose-intensified chemotherapy and leads to in vivo selection of hematopoietic stem cells.
Cancer Res. 60, 5187-5195
REESE, J. S., O. N. KOC, K. M. LEE, L. LIU, J. A. ALLAY, W. P. PHILLIPS, JR. u. S.
l transduction of a mutant methylguanine DNA methyltransferase lls confers resistance to O6-benzylguanine plus 1,3-bis(2-chloroethyl)-1-nitrosourea.
L. GERSON (1996):
Retrovira
gene into human CD34 ce
Proc. Natl. Acad. Sci. U S A 93, 14088-14093
DER, T., A. BRUN, R. G. HAWLEY, S. KARLSSON u. J. RICHTER (2001):
Retroviral transduction of human CD34+ cells on fibronectin fragment CH-296 is inhibited by high concentrations of vector
RELAN
containing medium.
J. Gene Med. 3, 207-218
RETH
The replication strategy of foamy viruses.
WILM, A. (2003):
Curr. Top. Microbiol. Immunol. 277, 1-26
ROE,
ne leukemia virus DNA depends on mitosis.
T., T. C. REYNOLDS, G. YU u. P. O. BROWN (1993):
Integration of muri Embo J. 12, 2099-2108
RUSSELL, D. W., u. A. D. MILLER (1996):
Foamy virus vectors.
J. Virol. 70, 217-222
RUSTIGIAN, R., P. JOHNSTON u. H. REIHART (1955):
Infection of monkey kidney tissue cultures with virus-like agents.
Proc. Soc. Exp. Biol. Med. 88, 8-16
, M. D., A. M. KING u. G. P
RYAN . THOMAS (1991):
disease virus polyprotein is mediated by residues located within a 19 amino acid sequence.
Cleavage of foot-and-mouth
J. Gen. Virol. 72 ( Pt 11), 2727-2732
SCHA
l and lentiviral SIN vectors for expression of ematopoietic cells.
Mol. Ther. 13
MBACH, A., J. BOHNE, S. CHANDRA, E. WILL, G. P. MARGISON, D. A.
WILLIAMS u. C. BAUM (2006):
Equal potency of gammaretrovira
O6-methylguanine-DNA methyltransferase in h , 391-400
SCHLE
dylserine: is -binding site?
Cell 32
GEL, R., T. S. TRALKA, M. C. WILLINGHAM u. I. PASTAN (1983a):
Inhibition of VSV binding and infectivity by phosphati phosphatidylserine a VSV
, 639-646
SCHLE
"receptor".
GEL, R., u. M. WADE (1983b):
Neutralized vesicular stomatitis virus binds to host cells by a different
Biochem. Biophys. Res. Commun. 114, 774-778
SCHMIDT, M., u. A. RETHWILM (1995):
Replicating foamy virus-based vectors directing high level expression of foreign genes.
Virology 210, 167-178
SCHMIDT, M., P. ZICKLER, G. HOFFMANN, S. HAAS, M. WISSLER, A. MUESSIG, . KIEM, C. E.
Polyclonal long-term repopulating stem cell clones in a primate model.
J. F. TISDALE, K. KURAMOTO, R. G. ANDREWS, T. WU, H. P DUNBAR u. C. VON KALLE (2002):
Blood 100, 2737-2743
SCHR RY, J. R. ECKER u. F. BUSHMAN
HIV-1 integration in the human genome favors active genes and local hotspots.
ODER, A. R., P. SHINN, H. CHEN, C. BER (2002):
Cell 110, 521-529
SCHW
ted from an accidentally infected human individual.
J. Virol. 71
EIZER, M., V. FALCONE, J. GANGE, R. TUREK u. D. NEUMANN-HAEFELIN (1997):
Simian foamy virus isola , 4821-4824
SEGG
. S. YOUNG, 3RD, R. E. DONAHUE, . W. NIENHUIS u. C. E. DUNBAR (2006):
Acute myeloid leukemia is associated with retroviral gene transfer to a rhesus macaque.
EWISS, R., S. PITTALUGA, R. L. ADLER, F. J. GUENAGA, C. FERGUSON, I.
H. PILZ, B. RYU, B. P. SORRENTINO, W C. VON KALLE, A
hematopoietic progenitor cells in Blood 107, 3865-3867
SONE . GRIFFITHS, G. ROMANO,
S. M. KINGSMAN u. A. J. KINGSMAN (1995):
ion system for the production of high titer
es. 23
OKA, Y., P. M. CANNON, E. E. RAMSDALE, J. C
A transient three-plasmid express retroviral vectors.
Nucleic Acids R , 628-633
SPANGRUDE, G. J., D. M. BROOKS u. D. B. TUMAS (1995):
Long-term repopulation of irradiated mice with limiting numbers of purified hematopoietic stem cells: in vivo expansion of stem cell phenotype but not function.
Blood 85, 1006-1016
SPANGRUDE, G. J., S. HEIMFELD u. I. L. WEISSMAN (1988):
Purification and characterization of mouse hematopoietic stem cells.
Science 241, 58-62
TANKE, N., A. STANGE, D. LUFTENEGGER, H. ZENTGRAF u. D. LINDEMANN
ation of the prototype foamy virus envelope glycoprotein leader S
(2005):
Ubiquitin
peptide regulates subviral particle release.
J. Virol. 79, 15074-15083
ns derived from STITZ, J., C. J. BUCHHOLZ, M. ENGELSTADTER, W. UCKERT, U. BLOEMER, I.
SCHMITT u. K. CICHUTEK (2000):
Lentiviral vectors pseudotyped with envelope glycoprotei gibbon ape leukemia virus and murine leukemia virus 10A1.
Virology 273, 16-20
ANAKA, J., H. SADANARI, H. SATO u. S. FUKUDA (1991):
T
Sodium butyrate-inducible replication of human cytomegalovirus in a human epithelial cell line.
Virology 185, 271-280
THOM
Bone marrow transplantation: a review.
Semin. Hematol. 36 AS, E. D. (1999):
, 95-103
THOMAS, E. D., H. L. LOCHTE, W. C. LU u. J. W. FERREBEE (1957):
. Med. 157
Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy.
N. Engl. J , 491-496
O, L. B., D. N. HAYLOCK, P. J. SIMMONS u. C. A. JUTTNER (1997):
T
The biology and clinical uses of blood stem cells.
Blood 89, 2233-2258
ROBRIDGE, G., u. D. W. RUSSELL (2004):
oncovirus and lentivirus vectors.
T
Cell cycle requirements for transduction by foamy virus vectors compared to those of
J. Virol. 78, 2327-2335
TROB ER, M. A. JACOBS, J. M. ALLEN, H. P. KIEM, R.
KAUL u. D. W. RUSSELL (2006):
RIDGE, G. D., D. G. MILL
Foamy virus vector integration sites in normal human cells.
Proc. Natl. Acad. Sci. U S A 103, 1498-1503
TROB
us vectors.
Hum. Gene Ther. 9
RIDGE, G. D., u. D. W. RUSSELL (1998):
Helper-free foamy vir
, 2517-2525
VAN D
. WILLIAMS (1998):
ere combined immunodeficiency (NOD/SCID) mouse as a model system to study the engraftment and mobilization of human
tem cells.
ER LOO, J. C. M., H. HANENBERG, R. J. COOPER, F. Y. LUO, E. N.
LAZARIDIS u. D. A Nonobese diabetic/sev
peripheral blood s Blood 92, 2556-2570
VASSILOPOULOS, G., G. TROBRIDGE, N. C. JOSEPHSON u. D. W. RUSSELL
nto murine hematopoietic stem cells with helper-free foamy
Blood 98 (2001):
Gene transfer i virus vectors.
, 604-609
VON L ROSCHER, B. FEHSE u. C.
Amphotropic and VSV-G-pseudotyped retroviral vectors transduce human ar efficiency.
AER, D., A. COROVIC, B. VOGT, U. HERWIG, S.
BAUM (2000):
hematopoietic progenitor cells with simil Bone Marrow Transplant. 25 Suppl 2, S75-79
WANG u. J. E. DICK (1997):
Primitive human hematopoietic cells are enriched in cord blood compared to
ing cell (SRC) assay.
, J. C. Y., M. DOEDENS
adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulat
Blood 89, 3919-3924
EISS, R. A. (1988):
disease.
W
Foamy retroviruses. A virus in search of a Nature 333, 497-498
ILLIAMS, D. A., I. R. LEMISCHKA, D. G. NATHAN u. R. C. MULLIGAN (1984):
W
Introduction of new genetic material into pluripotent haematopoietic stem cells of the mouse.
Nature 310, 476-480
MS, D. A., H. I. LEVITSKY, M
WILLIA . C. DINAUER u. D. W. RUSSELL (1997):
ematology: human diseases, mouse models and new approaches.
ASH Educ. Book 12 Genetic therapies in h
, 55-74
WINKLER, I. G., R. M. FLÜGEL, K. ASIKAINEN u. R. L. FLOWER (2000):
Antibody to human foamy virus not detected in individuals treated with blood products or in blood donors.
Vox. Sang. 79, 118-119
U, M., u. A. MERGIA (1999):
W
Packaging cell lines for simian foamy virus type 1 vectors.
J. Virol. 73, 4498-4501
WU, X
me are favored targets for MLV integration.
., Y. LI, B. CRISE u. S. M. BURGESS (2003):
Transcription start regions in the human geno
Science 300, 1749-1751
XU-WE
rase mutants highly by O6-benzylguanine.
Cancer Res. 58
LLIVER, M., S. KANUGULA u. A. E. PEGG (1998):
Isolation of human O6-alkylguanine-DNA alkyltransfe resistant to inactivation
, 1936-1945
YANG , B. ROESSLER u. K. T.
Highly efficient genetic transduction of primary human synoviocytes with , J., M. S. FRIEDMAN, H. BIAN, L. J. CROFFORD
MCDONAGH (2002):
concentrated retroviral supernatant.
Arthritis Res. 4, 215-219
YANG, P., M. ZEMBA, M. ABOUD, R. M. FLUGEL u. M. LOCHELT (1997):
Deletion analysis of both the long terminal repeat and the internal promoters of the human foamy virus.
Virus Genes 15, 17-23
YEE, J. K., T. FRIEDMANN u. J. C. BURNS (1994):
Generation of high-titer pseudotyped retroviral vectors with very broad host range.
Methods Cell. Biol. 43, 99-112
S (1995):
YODER, M. C., u. D. A. WILLIAM
Matrix molecule interactions with hematopoietic stem cells.
Exp. Hematol. 23, 961-967
u. M. OGAWA (1996):
ic stem cells.
A 93
YONEMURA, Y., H. KU, F. HIRAYAMA, L. M. SOUZA
Interleukin 3 or interleukin 1 abrogates the reconstituting ability of hematopoiet
Proc. Natl. Acad. Sci. U S , 4040-4044
YU, J. (1996):
Regulation and reconstitution of human hematopoiesis.
J. Formos Med. Assoc. 95, 281-293
U, S. F., u. M. L. LINIAL (1993):
uantitative assay.
Y
Analysis of the role of the bel and bet open reading frames of human foamy virus by using a new q
J. Virol. 67, 6618-6624
YU, S. . L. LINIAL (1999):
Evidence that the human foamy virus genome is DNA.
F., M. D. SULLIVAN u. M
J. Virol. 73, 1565-1572
Danksagung
Mein Dank gilt Prof. Dr. Helmut Hanenberg für die Überlassung des äußerst interessanten Themas, die fachliche Unterstützung bei virologischen Fragen, seine
tändige Diskussionsbereitschaft und seine Betreuung bei dieser Arbeit.
Herrn erzeit angebotene,
gute f stets gewährte Diskussionsbereitschaft und die onstruktive Kritik bei der Anfertigung der Arbeit, trotz der großen Entfernung. Vielen
Mein rof. Dr. Heiner Niemann; Institut für Tierzucht,
Bunde nsee, für die Betreuung der Arbeit
nd Verteidigung an der Stiftung Tierärztliche Hochschule Hannover.
Bei de Rethwilm möchte ich
mich für die gute Zusammenarbeit, die fachlich Unterstützung und vielen gute atschläge im Umgang mit Foamyviren bedanken.
Ich da
eine angenehme Arbeitsatmosphäre sowie für die ständige Gesprächsbereitschaft und Unterstützung bei Problemlösungen, insbesondere Herrn Dr. Michael Gombert
r die Einführung in die Geheimnisse von Microsoft-Word.
Gedan und Ingrid Wurm und
meine Bastian für die große Geduld und Aufmunterung bei er Fertigstellung der Arbeit.
esonderer Dank gilt Heiko Nathues, der nicht nur viel Geduld bei der Erstellung ieser Arbeit mit mir bewies, sondern mich auch im Vorfeld der Finalisierung dieses
erks stets motivierte, nicht den Kopf in den Sand zu stecken. Danke s
PD. Dr. Peter A. Horn danke ich ganz besonders für die jed achliche Unterstützung, die
k
Dank auch für die Unterstützung meiner Auslandsaufenthalte.
verbindlicher Dank gilt P
sforschungsanstalt für Landwirtschaft, Marie u
n Virologen Herrn Dr. Dirk Lindemann und Prof. Axel
R
nke allen Mitarbeiterinnen und Mitarbeitern des KMT-Labor der Kinderklinik für
fü
kt sei an dieser Stelle auch meinen Eltern, Rainer n Brüdern Bernhard und
d
B d W